ReviewWorld journal of microbiology & biotechnology2018
Yarrowia lipolytica: a beneficious yeast in biotechnology as a rare opportunistic fungal pathogen: a minireview.
Review in World journal of microbiology & biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 89 citations in OpenAlex.
- Cutaneous candidal infection caused byJAAD case reports · 2026Article
- Synthesis of Plant-InspiredACS synthetic biology · 2026Article
- An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025Review
- Myco- and microbiological profiling of a human cadaver reveals drug-resistant strains and new fungal records.Applied microbiology and biotechnology · 2025Article
- Molecular Triggers of Yeast Pathogenicity in the Yeast-Host Interactions.Current issues in molecular biology · 2025Review
- Multi-Omics Analysis Reveals 1-Propanol-Induced Pentadecanoic Acid Biosynthesis inBiomolecules · 2025Article
- Ecological factors that drive microbial communities in culturally diverse fermented foods.BMC microbiology · 2025Article
- Internal transcribed spacer sequencing to explore the intrinsic composition of fungal communities in fungal esophagitis.World journal of gastroenterology · 2025Article
- Targeting the mycobiome in sarcoidosis.Frontiers in medicine · 2025Article
- Potential role of alginate in marine bacteria-yeast interactions.Applied and environmental microbiology · 2024Article
- Tracking trash to treasure:RSC advances · 2024Article
- Potential of oleaginous microbes for lipid accumulation and renewable energy generation.World journal of microbiology & biotechnology · 2024Review
- Antifungal susceptibility profile and local epidemiological cut-off values ofMicrobiology spectrum · 2024Article
- Dynamics of the lipid body lipidome in the oleaginous yeast Yarrowia sp.FEMS yeast research · 2024Article
- Mushrooms Adapted to Seawater: Two New Species ofJournal of fungi (Basel, Switzerland) · 2023Article
- Enhanced β-carotene production in Yarrowia lipolytica through the metabolic and fermentation engineering.Journal of industrial microbiology & biotechnology · 2023Article
- Biotechnological Production of Sustainable Microbial Proteins from Agro-Industrial Residues and By-Products.Foods (Basel, Switzerland) · 2022Review
- First Isolation ofPathogens (Basel, Switzerland) · 2022Article
- Proteomic Study of Response to Copper, Cadmium, and Chrome Ion Stress inMicroorganisms · 2022Article
- Alterations in the Gut Fungal Community in a Mouse Model of Huntington's Disease.Microbiology spectrum · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Yarrowia lipolytica is one of the most studied "non-conventional" yeast species capable of synthesizing a wide group of valuable metabolites, in particular lipases and other hydrolytic enzymes, microbial oil, citric acid, erythritol and γ-decalactone. Processes based on the yeast have GRAS status ("generally recognized as safe") given by Food and Drug Administration. The majority of research communications regarding to Y. lipolytica claim that the yeast species is non-pathogenic. In spite of that, Y. lipolytica, like other fungal species, can cause infections in immunocompromised and critically ill patients. The yeast possess features that facilitate invasion of the host cell (particularly production of hydrolytic enzymes), as well as the protection of the own cells, such as biofilm formation. The aim of this study was to present well-known yeast species Y. lipolytica as a rare opportunistic fungal pathogen. Possible pathogenicity and epidemiology of this yeast species were discussed. Antifungal drugs susceptibility and increasing resistance to azoles in Y. lipolytica yeasts were also presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.